SELLAS Life Sciences SLS
NASDAQ SLS
$12.14 +0.16 (+1.34%)
At close: Oct 21, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) EV to CFO (2017)

Updated

SELLAS Life Sciences' EV to CFO was 26.94 in Q3 2017, down 74.5% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) EV to CFO (2017) Analysis & Trends

On a trailing twelve-month basis, SELLAS Life Sciences' EV to CFO was 24.27 through Sep 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 SELLAS Life Sciences 2.30 Bn 1.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 26.94
Jun 30, 2017 105.46
API Access

SELLAS Life Sciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SLS&period=max&api_key=YOUR_API_KEY